Diaceutics is redefining drug commercialisation — so diagnostic intelligence drives action and no patient is left waiting for the right therapy.
Before anything else is applied, these are the non-negotiables. The rules that every piece of Diaceutics communication must pass, regardless of channel, audience or format.
The primary and extended palettes define the core visual identity of Diaceutics. Secondary colours are data visualisation only — never in navigation, headers, buttons or body content.
Two separate Adobe Fonts families — acumin-pro-extracondensed-bl (Mid-Black 800) for headers and acumin-pro-condensed-black (Light 300, Bold 700 for emphasis) for body. They share no weights in common usage.
How the two families are deployed across touchpoints. Headlines lead the brand voice; body type carries the detail. Switch tabs to explore each.
Our tone of voice reflects who we are becoming: a confident challenger redefining the commercialisation of diagnostic-driven therapies. If it doesn't add value — cut it.
The Diaceutics digital system translates the visual identity into responsive, accessible web and application environments. Toolkit and application examples to follow as the brand rolls out across web, paid media and product.